A Cluster of Cefepime-induced Neutropenia During Outpatient Parenteral Antimicrobial Therapy
- PMID: 30590400
- PMCID: PMC6637276
- DOI: 10.1093/cid/ciy1112
A Cluster of Cefepime-induced Neutropenia During Outpatient Parenteral Antimicrobial Therapy
Abstract
A cluster of cefepime-induced neutropenia (CIN) was identified from June 2017 to May 2018 in a regional outpatient parenteral antimicrobial therapy population. Our data suggest prolonged courses of cefepime (≥2 weeks), administered by rapid intravenous push, were associated with a higher risk of CIN.
Keywords: OPAT; adverse drug event; cefepime; cefepime-induced neutropenia; drug-induced neutropenia.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
References
-
- Norris AH, Shrestha NK, Allison GM, et al. . IDSA clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 2019; 68:e1–35. - PubMed
-
- Hospira. Maxipime (cefepime) [prescribing information]. Lake Forest, Illinois: Hospira, 2017.
-
- Dahlgren AF. Two cases of possible cefepime-induced neutropenia. Am J Health Syst Pharm 1997; 54:2621–2. - PubMed
-
- Wong BB, Ko GJ. Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis. Am J Health Syst Pharm 2003; 60:2229–32. - PubMed
-
- Hettmer S, Heeney MM. Cefepime-induced neutropenia in a teenager. Pediatr Blood Cancer 2008; 51:715–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical